A Crisis Measured in Caskets

In 2024, the United States recorded over 107,000 drug overdose deaths. Synthetic opioids — primarily illicitly manufactured fentanyl — were involved in approximately 73% of those deaths. That's roughly 200 people every single day.

These aren't statistics. They're parents, children, veterans, workers, and neighbors. And despite decades of drug policy, billions in enforcement spending, and an ever-expanding list of prohibited substances, the numbers continue to climb.

Against this backdrop, a growing body of evidence suggests that access to botanical alternatives like kratom may represent one of the few tools capable of reducing harm at scale. And yet, state after state continues to ban or restrict these alternatives — often with the stated goal of public safety.

How Fentanyl Changed Everything

Fentanyl is not a new drug. It has legitimate medical uses in clinical settings where precise dosing is controlled by trained professionals. What changed is the illicit manufacturing and distribution of fentanyl and its analogs.

Key facts about the current crisis:

  • Fentanyl is 50-100 times more potent than morphine
  • A lethal dose can be as small as 2 milligrams — virtually invisible
  • It has been found in counterfeit pills, heroin, cocaine, methamphetamine, and other street drugs
  • Many overdose victims did not know they were consuming fentanyl
  • Standard naloxone (Narcan) doses sometimes require multiple administrations for fentanyl overdoses

In this environment, any substance that keeps people away from the illicit drug supply has potential public health value. Kratom, despite its imperfections, is one such substance.

The Harm Reduction Framework

Harm reduction is a public health philosophy that prioritizes reducing the negative consequences of substance use rather than demanding abstinence as the only acceptable outcome. It's the framework behind needle exchange programs, supervised consumption sites, naloxone distribution, and medication-assisted treatment.

The core principle is pragmatic: people who are alive can get better; people who are dead cannot.

Within this framework, kratom occupies an interesting position. Multiple surveys of kratom users have found that significant percentages report using kratom specifically to:

  • Reduce or eliminate opioid use
  • Manage chronic pain without prescription opioids
  • Manage withdrawal symptoms during self-directed opioid tapering
  • Avoid returning to street drugs during recovery

A 2020 study in the Journal of Addiction Medicine found that among kratom users who had previously used opioids, the majority reported decreased opioid use after incorporating kratom. While this is self-reported data with inherent limitations, the consistency of these findings across multiple studies is notable.

What Other Countries Are Doing

The United States is not the only country grappling with these questions, but it is one of the few taking a predominantly prohibitionist approach to botanical alternatives.

Portugal decriminalized all drugs in 2001 and invested in harm reduction services. Overdose deaths dropped by over 80% in the following decade.

Switzerland implemented heroin-assisted treatment programs for people who didn't respond to other interventions. Overdose deaths dropped. Crime dropped. Employment increased.

Thailand — where kratom is native — legalized kratom in 2022 after decades of prohibition, recognizing that the ban was causing more harm than the substance itself.

The common thread: pragmatic, evidence-based approaches that prioritize outcomes over ideology.

The Cost of Getting This Wrong

Every policy decision about kratom has real human consequences. When a state bans kratom:

  • People who were using it to avoid opioids lose access to their alternative
  • Some will return to the illicit drug market — and face fentanyl exposure
  • Others will suffer untreated chronic pain
  • Criminal penalties create barriers to employment and housing
  • Stigma prevents people from discussing their use honestly with healthcare providers

When a state regulates kratom responsibly:

  • Products are tested for contaminants and accurate labeling
  • Youth access is restricted through age verification
  • Concentration limits prevent dangerously potent products
  • Consumers can make informed decisions based on published data
  • Tax revenue funds public health programs

The evidence is clear: regulation saves lives; prohibition costs them.

What We Believe

We sell kratom products. We acknowledge that kratom is not without risks. We believe that transparency — through published lab results, honest product information, and responsible marketing — is the best way to minimize those risks.

We also believe that access to tested, accurately labeled botanical products is infinitely safer than the alternative of pushing people toward an unregulated street supply contaminated with fentanyl.

The fentanyl crisis will not be solved by adding more substances to the prohibited list. It will be solved by expanding access to safer alternatives, investing in treatment, and trusting people with honest information. Check your state's current laws at our Regulation Terminal.

Disclaimer: This article is for informational purposes only and does not constitute medical or legal advice. Kratom products sold by Favor'd Alkz are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.

Last updated: April 2026